Genpharmasec Limited (BOM:531592)
India flag India · Delayed Price · Currency is INR
1.130
0.00 (0.00%)
At close: Jun 17, 2026

Genpharmasec Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
16.0312.31-1.6911.25-2.09
Depreciation & Amortization
21.688.120.420.20.14
Loss (Gain) From Sale of Assets
----0.09
Loss (Gain) From Sale of Investments
0.47----
Provision & Write-off of Bad Debts
6.963.944.271.75-
Other Operating Activities
-25.73-16.692.95-6.1-3.3
Change in Accounts Receivable
-153.47-48.9-33.917.3910.77
Change in Inventory
-57.186.458.332.13-22.08
Change in Accounts Payable
229.0758.810.09-48.51-8.95
Change in Other Net Operating Assets
-213.375.84-19.921.291.98
Operating Cash Flow
-175.5229.87-29.46-30.6-23.44
Capital Expenditures
-5.21-57.05-0.18-0.16-0.81
Sale of Property, Plant & Equipment
----0.02
Investment in Securities
-42.15--176.43.332.73
Other Investing Activities
7.6922.834.730.230.66
Investing Cash Flow
132.63-152.98-280.633.634.18
Long-Term Debt Issued
56.95-54.830.4-
Long-Term Debt Repaid
-7.27-6.23-57.64--
Net Debt Issued (Repaid)
49.69-6.23-2.8430.4-
Issuance of Common Stock
--484.51--
Other Financing Activities
-10.48-6.26-3.20.42-
Financing Cash Flow
39.21-12.49478.4730.82-
Miscellaneous Cash Flow Adjustments
6.910---
Net Cash Flow
3.24-135.6168.383.85-19.26
Free Cash Flow
-180.73-27.19-29.64-30.76-24.25
Free Cash Flow Margin
-12.91%-8.06%-9.75%-12.05%-8.88%
Free Cash Flow Per Share
-0.29-0.05-0.10-0.11-0.09
Cash Interest Paid
10.486.263.75--
Cash Income Tax Paid
9.930.740.41-2.550.3
Levered Free Cash Flow
-209.75-9.09-29.15-43.65-44.21
Unlevered Free Cash Flow
-202-6.37-26.59-43.3-44.21
Change in Working Capital
-194.9422.18-35.41-37.69-18.28